Literature DB >> 17356291

Infertility in cryptorchidism is linked to the stage of germ cell development at orchidopexy.

Faruk Hadziselimovic1, Burckhard Hocht, Bruno Herzog, Mauro W Buser.   

Abstract

BACKGROUND: Cryptorchidism represents the most common endocrine disease in boys, with infertility frequently observed in unilateral as well as bilateral forms. In this study, we examined the role of Ad (dark) spermatogonia for fertility in cryptorchid boys. The hypothesis to be proven was that boys lacking Ad spermatogonia will develop infertility despite a successful orchidopexy at an early age.
METHODS: To estimate total sperm count, one of the most predictive parameters of male fertility, we analyzed the ejaculatein 218 cryptorchid men and correlated it with the developmental stage of their germ cells at the time of successful surgery.
RESULTS: Abnormal sperm concentration (<40 x 10(6)/ejaculate) was found in half of the patients under the study. 47.5% of unilateral and 78% of bilateral cryptorchid males had their sperm concentration in the infertility range according to the WHO standards. If transformation into Ad spermatogonia had occurred, age-related differences in the fertility outcome was observed. The younger the unilateral cryptorchid boys were at surgery, the higher their sperm count. Age-related difference was not found in the group of cryptorchid men having had no A dark spermatogonia at time of surgery, indicating that in this group a successful orchidopexy is insufficient to prevent infertility development and, in particular, the development of azoospermia.
CONCLUSION: The presence of Ad spermatogonia at surgery is an excellent prognostic parameter for future fertility. Cryptorchid boys lacking these cells will develop infertility despite successful orchidopexy at an early age. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17356291     DOI: 10.1159/000100874

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  29 in total

1.  The controversy regarding the need for hormonal treatment in boys with unilateral cryptorchidism goes on: a review of the literature by B. Ludwikowski and R. González.

Authors:  Faruk Hadziselimovic
Journal:  Eur J Pediatr       Date:  2012-04-21       Impact factor: 3.183

Review 2.  Physical deformities relevant to male infertility.

Authors:  Rajender Singh; Alaa J Hamada; Laura Bukavina; Ashok Agarwal
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

Review 3.  [Undescended testis: current treatment guidelines].

Authors:  B Haid
Journal:  Urologe A       Date:  2016-01       Impact factor: 0.639

4.  [Late diagnosis of cryptorchidism].

Authors:  I Körner; C Neissner; J Steckermeier; W H Rösch
Journal:  Urologe A       Date:  2009-09       Impact factor: 0.639

5.  [Cryptorchidism and infertility from the perspective of interdisciplinary guidelines].

Authors:  M J Mathers; S Degener; S Roth
Journal:  Urologe A       Date:  2011-01       Impact factor: 0.639

Review 6.  [Cryptorchidism and fertility].

Authors:  I Rübben
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

7.  [Undescended testis: aspects of treatment].

Authors:  I Körner; H Rübben
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 8.  The controversy regarding the need for hormonal treatment in boys with unilateral cryptorchidism goes on: a review of the literature.

Authors:  Barbara Ludwikowski; Ricardo González
Journal:  Eur J Pediatr       Date:  2012-03-07       Impact factor: 3.183

Review 9.  Regulation of testicular descent.

Authors:  John M Hutson; Ruili Li; Bridget R Southwell; Don Newgreen; Mary Cousinery
Journal:  Pediatr Surg Int       Date:  2015-02-18       Impact factor: 1.827

10.  Colour Doppler and ultrasound characteristics of testicular Leydig cell tumours.

Authors:  Florian Maxwell; Vincent Izard; Sophie Ferlicot; Antoine Rachas; Jean-Michel Correas; Gérard Benoit; Marie-France Bellin; Laurence Rocher
Journal:  Br J Radiol       Date:  2016-04-13       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.